Triptorelin
Also known as: Decapeptyl, Trelstar, GnRH Superagonist, D-Trp6-LHRH
Triptorelin is a synthetic decapeptide analog of gonadotropin-releasing hormone (GnRH) with 100x the potency of native GnRH. An FDA-approved drug (Trelstar) for prostate cancer and precocious puberty, it is also used in post-cycle therapy (PCT) to rapidly restart the hypothalamic-pituitary-gonadal (HPG) axis after anabolic steroid suppression.
Half-Life
Depot forms: weeks to months; aqueous: 6-8 hours
Route
SubQ, IM
Category
Sexual Health & Libido
Studies
50 references
Key Benefits
- Rapid HPG axis restart after steroid use
- Single-injection PCT protocol possible
- Massively elevates LH and FSH via flare effect
- Restores endogenous testosterone faster than traditional PCT
- FDA-approved for established medical uses
Mechanism of Action
As a GnRH superagonist, a single large dose causes massive LH and FSH release (flare effect), which can jumpstart endogenous testosterone production. This distinguishes it from pulsatile GnRH (gonadorelin) — one injection provides a powerful, sustained HPG stimulation. With repeated dosing, it paradoxically causes HPG suppression (used in prostate cancer).
Dosing Protocols
PCT Single-Shot Protocol
- Dose
- 100 mcg
- Frequency
- Single injection
- Timing
- 1-2 weeks after last steroid dose
- Cycle
- One-time use for PCT
Causes acute LH/FSH surge to jumpstart HPG axis; follow with SERMs if needed
Medical Depot Formulation
- Dose
- 3.75 mg depot
- Frequency
- Once monthly
- Timing
- IM or SC depot injection
- Cycle
- Ongoing for prostate cancer
Medical use only; causes HPG suppression not stimulation at this dosing regimen
Calculate your draw volume
Enter your vial size and BAC water to get exact injection volumes
Side Effects
- Initial testosterone flare (intended)
- Injection site reactions
- Hot flashes (with chronic use)
- Decreased libido (chronic dosing)
Storage
Lyophilized: refrigerate at 2-8°C. Reconstituted: use immediately.
Featured In Stacks
Clinical Research
- 1.Effect of emulsion-based nanosystems on the encapsulation behavior of triptorelin using molecular dynamics simulation
Nejati F, Ahmadian N, Yahyaei M, Mehrnejad F · Journal of computer-aided molecular design · 2026PubMed Verified
- 2.Challenges in analyzing real-world evidence: analysis of androgen deprivation therapy use for prostate cancer in the REASSURE study
Tran B, Yeh N, Gayle A, Holmes E, Hu J, Damineni S et al. · ESMO real world data and digital oncology · 2025ReviewPubMed Verified
- 3.Effects of silybin on triptorelin-induced bone metabolic abnormalities in prostate cancer revealed based on TMT-based proteomics
Li J, Lv X, Jiang Y · PloS one · 2026PubMed Verified
- 4.Efficacy and outcomes of 6-month triptorelin formulation in girls treated for central precocious puberty for 24 months and beyond
Foreman A, Klein KO, Vargas Trujillo M · Journal of pediatric endocrinology & metabolism : JPEM · 2026PubMed Verified
- 5.GnRH Administration Increases Synchronisation of Ovulation in Mares
Cui B, Liu Y, Wu X, Li X · Reproduction in domestic animals = Zuchthygiene · 2026PubMed Verified
- 6.Benefits of Implant Use in the Cow/Calf and Backgrounding Sectors
Sperber JL, Nuttelman B, MacDonald J · The Veterinary clinics of North America. Food animal practice · 2026ReviewPubMed Verified
- 7.Long-term trends in androgen-directed therapy in advanced prostate cancer: a 29-year national analysis
Sandhu K, Wells C, Newton MMH, Murphy DG, Lawrentschuk N, Perera ML · International urology and nephrology · 2026PubMed Verified
- 8.Design and synthesis of graphite/Ni/Cu/triptorelin peptide electrocatalyst for hydrogen production and storage
Ferdowsi GS, Jafarian M, Ramezanpour S, Aghamirza Moghim Aliabadi H · Scientific reports · 2026PubMed Verified
- 9.Diagnostic accuracy of the triptorelin stimulation test for central precocious puberty in girls
Chioma L, Bizzarri C, Longobardi M, Mainieri F, Porzio O, D'Agostini M et al. · Endocrine connections · 2025PubMed Verified
- 10.Feasibility and efficacy of random-start progestin-primed ovarian stimulation: a multicenter pilot randomized controlled trial in oocyte donation
Mathieu d'Argent E, Guivarc'h-Leveque A, Catteau-Jonard S, Cedrin-Durnerin I, Peigné M, Jung C et al. · Reproductive biology and endocrinology : RB&E · 2025PubMed Verified
- 11.Deslorelin influences canine epididymal gene expression of the androgen receptor and prostaglandin metabolism
Greiner H, Packeiser EM, Körber H, Stempel S, Freise F, Goericke-Pesch S · Animal reproduction science · 2026PubMed Verified
- 12.A retrospective analysis of spontaneous reports of suspected adverse drug reactions to triptorelin acetate in a tertiary pediatric medical center: still a lot of preventable harm
Cao Z, Cheng J, Chen Z, Lei X, Yang L, Zhan M et al. · BMC pediatrics · 2025PubMed Verified
- 13.The Diagnostic Utility of the Triptorelin Stimulation Test Compared to the Standard Gonadotropin-Releasing Hormone Stimulation Test in Children with Idiopathic Central Precocious Puberty
Sodero G · Diseases (Basel, Switzerland) · 2025PubMed Verified
- 14.Triptorelin: The Need for Legal Protection Aimed at the Full Political and Social Integration of Gender Variant youth. A Comparison of Different Global realities
Lacasella G, Volonnino G, Salducci M, Ottavian M, Spadazzi F, Karaboue MAA et al. · La Clinica terapeutica · 2025ReviewPubMed Verified
- 15.Racial Differences in Adverse Events After Androgen Deprivation in Veterans With Prostate Cancer
Friedrich NA, Janes JL, Parrish J, De Hoedt AM, Josan K, Tatonetti NP et al. · JAMA network open · 2025PubMed Verified
- 16.A case of congenital long QT syndrome and medically induced menopause
Wilkinson JF, Williams PL, Green JC, Modi S, Briggs PE · Post reproductive health · 2025Case ReportPubMed Verified
- 17.Is the triptorelin stimulation test comparable to the gonadorelin stimulation test in diagnosing central precocious puberty in boys?
Seo JH, Yoo MJ, Lee K, Choi J, Choe Y, Yang S · Annals of pediatric endocrinology & metabolism · 2025PubMed Verified
- 18.Efficacy of Huayu Xiaozheng decoction combined with triptorelin and mifepristone in the treatment of uterine fibroids and its effect on uterine artery hemodynamics
Zhou Y, Liu X, Yang X, Yu Y, Zhou Y, Zhou H · International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2025PubMed Verified
- 19.Treatment of aggressive prostate cancer with triptorelin in real life in France: the TALISMAN study
Lebret T, Crehange G, Pello-Leprince-Ringuet N, Perrot V, Rigaud J · Therapeutic advances in urology · 2025PubMed Verified
- 20.The value of urinary gonadotropin after triptorelin stimulation tests for diagnosing central precocious puberty in girls with overweight or obesity: a single-center study
Zeng B, Zhou Y, Jia R, Kong FS, Huang P, Chen M et al. · BMC pediatrics · 2025PubMed Verified
- 21.Serum proteomic profiling during the periovulatory period identifies preliminary candidate biomarkers of oocyte maturation in deslorelin-induced ovulation in dogs
Udomthanaisit L, Roytrakul S, Kallayanathum W, Charoenlappanit S, Tharasanit T · PeerJ · 2025PubMed Verified
- 22.DEVELOPMENT AND VALIDATION OF DESLORELIN ACETATE ASSAY AND A PILOT STUDY ON THE PHARMACOKINETICS OF DESLORELIN ACETATE IMPLANTS AND FECAL HORMONE MONITORING IN THE DOMESTIC GOAT (CAPRA HIRCUS)
Rooney TA, Lehner A, Zyskowski J, Thompson KA, Eustace R, Kozlowski CP et al. · Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians · 2025PubMed Verified
- 23.Effects of GnRH administration on pregnancy rate and litter size in ewes subjected to a fixed time insemination program during the breeding season
Cui B, Hapaer A, Wu X, Liu Y, Li X · Animal reproduction science · 2025PubMed Verified
- 24.Cost-effectiveness of dienogest compared to gonadotropin releasing hormone agonists for the management of endometriosis in Vietnam
Kieu MTT, Le MH, Nguyen CP · Cost effectiveness and resource allocation : C/E · 2025PubMed Verified
- 25.Effectiveness and Safety of Postoperative Medical Treatments Following Fertility-Preserving Surgery for Endometriosis: A Network Meta-Analysis
Xiong Y, Huang W, Wang C, Ma W, Jin S, Lin J et al. · BJOG : an international journal of obstetrics and gynaecology · 2026Meta-AnalysisPubMed Verified
- 26.Clinical efficacy and influence on the quality of life of children with precocious puberty treated by combination of cluster nursing and triptorelin
Wang H, Chen J · Medicine · 2025RCTPubMed Verified
- 27.Role of triptorelin and single fixed-time artificial insemination on productive and reproductive performance of hyperprolific sows
Falceto MV, Reyero D, Tejedor MT, Renaud P, Mateu A, Lafuente A et al. · Veterinary and animal science · 2025PubMed Verified
- 28.Dual trigger vs. gonadotropin-releasing hormone agonist trigger for elective fertility preservation: a randomized controlled trial
Donno V, Neves AR, García-Martinez S, Rodriguez I, Polyzos NP · Fertility and sterility · 2025PubMed Verified
- 29.A single blood luteinizing hormone level of triptorelin stimulation test can diagnose hypothalamic-pituitary-gonadal axis activation in girls with high body mass index
Zeng B, Huang Y, Zhou Y, Li Y, Huang P, Xu Z et al. · Frontiers in pediatrics · 2025PubMed Verified
- 30.Treatment of overweight and obese girls experiencing central precocious puberty: a comparison of the effectiveness of leuprolide acetate and triptorelin pamoate
Thaneetrakool T, Aroonparkmongkol S, Chatdamrongsakool K, Numsriskulrat N, Supornsilchai V, Wacharasindhu S et al. · Annals of pediatric endocrinology & metabolism · 2025PubMed Verified
- 31.Commentary on "Treatment of overweight and obese girls experiencing central precocious puberty: a comparison of the effectiveness of leuprolide acetate and triptorelin pamoate"
Kim SH · Annals of pediatric endocrinology & metabolism · 2025PubMed Verified
- 32.Triptorelin associated adverse events evaluated using FAERS pharmacovigilance data
Jia W, Wang T · Scientific reports · 2025PubMed Verified
- 33.Triptorelin 0.1 mg as a Luteal Phase Support in Antagonist Intracytoplasmic Sperm Injection Cycles
Zahran KM, Ahmed MMA, Farghaly TA, Elsayed AA, El-Nashar IM · Journal of obstetrics and gynaecology of India · 2025PubMed Verified
- 34.Evaluation and management of incomplete ovarian function suppression in premenopausal breast cancer patients receiving anti-hormone therapy
Patel R, Weil E, Bugamelli S, Carroll E, Steinke K, Stockhausen E et al. · Breast cancer research : BCR · 2025PubMed Verified
- 35.Short-term Androgen Deprivation Therapy and High-dose Radiotherapy in Intermediate- and High-risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase 3 Trial
Demogeot N, Sargos P, Salleron J, Guérif S, de Crevoisier R, Calais G et al. · European urology · 2025RCTPubMed Verified
- 36.Urinary follicle-stimulating hormone during triptorelin stimulation test can monitor the efficacy of triptorelin depot in girls with precocious or early puberty
Zhou Y, Zeng B, Huang Y, Huang P, Li Y, Xu Z et al. · Archives de pediatrie : organe officiel de la Societe francaise de pediatrie · 2025PubMed Verified
- 37.Osteopontin expression in prepubertal and adult dog testes and the effect of slow-release deslorelin implants (Suprelorin® 4.7 mg)
Liman N, Balogh O, Fidan B, Müller L, Gram A · Domestic animal endocrinology · 2025PubMed Verified
- 38.Apalutamide-associated rash combined with severe neutropenia and eosinophilia: a case report
Shao Y, Liu Z, Zhang Y, Yang Z, Liu Y, Huang H et al. · AME case reports · 2025Case ReportPubMed Verified
- 39.AQbD-based development of a stability-indicating UHPLC-PDA-QDa method for triptorelin in parenteral formulations
Afonso Urich JA, Marko V, Fedorko A, Jeremic D · Analytical methods : advancing methods and applications · 2025PubMed Verified
- 40.The GnRH Agonist Triptorelin Causes Reversible, Focal, and Partial Testicular Atrophy in Rats, Maintaining Sperm Production
Marcos A, Rodríguez Del Cerro MC, Fernández RM, Pásaro E, Arias-Ramos N, López-Larrubia P et al. · International journal of molecular sciences · 2025PubMed Verified
- 41.Retrospective Analysis on the Impact of Triptorelin on Final Height of Girls with Precocious and Early Puberty: A Single-Center, Long-Term Study
Sotiriou G, Serbis A, Galli-Tsinopoulou A, Christoforidis A · Children (Basel, Switzerland) · 2025PubMed Verified
- 42.Adverse event profile differences among long-acting gonadotropin-releasing hormone analogs: A real-world, pharmacovigilance study
Chen Y, Lu W, Liao R, Zhang X, Chen W, Wang J et al. · PloS one · 2025PubMed Verified
- 43.Modified cytoskeletal and extracellular matrix composition in the canine testis after long-acting gonadotropin-releasing hormone agonist deslorelin treatment
Gram A, Abay M, Gram DY, Liman N, Müller L, Balogh O · Andrology · 2026PubMed Verified
- 44.DiWB-1: A Luteinizing Hormone Releasing Hormone (LHRH)-Targeted Peptide-Drug Conjugate (PDC) With Enhanced Tumor Selectivity and PI3K Inhibition Efficacy
Zhang C, Zhong H, Li X, Xing Z, Li S, Yu R et al. · Archiv der Pharmazie · 2025PubMed Verified
- 45.In vitro assessment of polyethylene glycol-coated iron oxide nanoparticles integrating luteinizing hormone releasing-hormone targeted magnetic hyperthermia and doxorubicin for lung and breast cancer cells
Srivastava N, Chudasama B, Baranwal M · Biointerphases · 2025PubMed Verified
- 46.Effects of Different Gonadotropin-Releasing Hormone Agonists on IVF/ICSI-ET Outcomes in Long Protocol: A Retrospective Study
Xu M, Li H, Zhao Y, Li H, Zhao C, Zhang X et al. · International journal of women's health · 2025PubMed Verified
- 47.Efficacy of first-year GnRHa therapy in girls with idiopathic central precocious puberty diagnosed after age 8: a retrospective study
Ni MM, Yang ST, Sun JY, Wu WW, Li M, Gu W et al. · Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2025PubMed Verified
- 48.Diagnosis Prostate Cancer via Molecular Computed Tomography Imaging based on Targeted Gold Nanoparticles
Ghorbani F, Abbasi S, Rabani F, Khademi S, Montazerabadi A · Cell journal · 2025PubMed Verified
- 49.Study of persistence and adherence to ADT in prostate cancer: relugolix, degarelix, and GnRH agonists in the US
Hafron J, Hong A, Ryan MJ, Romdhani H, Kinkead F, Flanders SC et al. · Future oncology (London, England) · 2025PubMed Verified
- 50.In vitro study of effect of gold nanoparticles conjugated with triptorelin peptide on the radiosensitivity of breast cancer cells (MCF-7)
Tavakkoli E, Hashemi SM, Montazerabadi A, Khademi S, Ghorbani F, Mohammadzadeh S et al. · Discover oncology · 2025PubMed Verified
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice. Many compounds listed are research chemicals not approved for human use. Always consult a qualified healthcare professional before starting any protocol.
Was this page helpful?
Launching soon
Build and track your protocol in Staqk
Log doses, track timing, monitor biomarkers, and manage every compound in your stack — all in one place.